Partnering

Out-licensing network

Angelini products are commercialised worldwide thanks to licensing out and export agreements with more than 40 partners.

The two key products of Angelini's research are the topical anti-inflammatory benzydamine and the anti-depressant trazodone.

Several other products are present in many markets in Europe and the Middle and Far East.

ThermaCare® is a key global brand in the field of Consumer Health care for which Angelini Pharma acquired global rights from GSK in March 2020

Active principles - Other products

• Paracetamol

  Markets	Partners	Brand	Use
  Albania, Kosovo	Medicamenta	Tachipirina®	Fever and pain
  Israel	Raz Pharmaceutics	Ramazol®	Fever and pain

• Progesterone

  Markets	Partners	Brand	Use
  Korea	Bekio	Yenatron®	Gynaecological use

• Glycerin

  Markets	Partners	Brand	Use
  Israel	Raz Pharmaceutics	Razalax®	Constipation

• Tetrahydrozoline

  Markets	Partners	Brand	Use
  Israel	Abic	Stilla®	Ophthalmic use

• Lactitol

  Markets	Partners	Brand	Use
  France	Serb	Importal®	Constipation
  Sweden, Holland	Navamedic	Importal®	Constipation
  Switzerland	Zambon	Importal®	Constipation

• Prulifloxacin

  Markets	Partners	Brand	Use
  Portugal	Mylan	Oliflox®	Antibiotic
  Italy	Crinos	Keraflox®	Antibiotic
  	SPA	Chinoplus®	Antibiotic

• Bendazac

  Markets	Partners	Brand	Use
  Japan	Sato	Zildasac®	Dermatitis
  	Iwaki	Iwazac®	Dermatitis

• Sodium hypochlorite

  Markets	Partners	Brand	Use
  France	Gifrer	Amukine®	Wound disinfectant
  Switzerland	Galephar	Amukine®	Wound disinfectant

• Oxolamine

  Markets	Partners	Brand	Use
  Israel	Teva	Symphocal®	Cough treatment

Our development portfolio

The development opportunities we offer include the products derived from the principal results of our research and others developed during recent activities.